Advertisement

Topics

Apollo Therapeutics Company Profile

01:11 EDT 16th June 2019 | BioPortfolio

The Apollo Therapeutics Fund is a unique collaboration between three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline and Johnson & Johnson) and the technology transfer offices (TTOs) responsible for commercialising the research from Imperial College London, UCL (University College London) and the University of Cambridge. The £40m fund will provide translational research funding for early-stage therapeutics projects arising from the three universities.


News Articles [926 Associated News Articles listed on BioPortfolio]

GI Dynamics, Apollo Sugar team up on EndoBarrier study in India

GI Dynamics and Apollo Sugar, an Apollo Health & Lifestyle-Sanofi collaboration, have entered an agreement to conduct a clini -More- 

Cambridge Enterprise: How Apollo Therapeutics is driving forward therapeutic innovation.

Iain Thomas, Head of Life Sciences at Cambridge University’s technology transfer arm, discusses the recent launch of Apollo Therapeutics, an ambitious collaboration between AstraZeneca, GlaxoSmithK...

Apollo Endosurgery, Inc. to Present at the JMP Securities 2019 Life Sciences Conference

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that company...

ReShape Lifesciences buys Apollo’s surgical product portfolio

Under the deal, ReShape Lifesciences has acquired surgical product line, including Lap-Band adjustable gastric banding system and other accessories used in laparoscopic bariatric surgery. Apollo has d...

Apollo Endosurgery enters loan agreement with Solar Capital

Apollo Endosurgery Inc. (minimally invasive devices for bariatric and gastrointestinal procedures) entered into a credit facility with Solar Capital. The company borrowed $35mm initially and could get...

Apollo Endosurgery, Inc. to Report First Quarter Results on May 2, 2019

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Com...

Study shows promising results for Apollo's OverStitch device

Data from a study that evaluated Apollo Endosurgery's OverStitch endoscopic suturing system for endoscopic gastroplasty showe -More- 

Apollo Endosurgery, Inc. to Report Fourth Quarter Results on March 18, 2019

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Com...

PubMed Articles [485 Associated PubMed Articles listed on BioPortfolio]

Astronaut Michael Collins, Apollo 8, and the anterior cervical fusion that changed the history of human spaceflight.

In 1961, President John F. Kennedy declared that the United States would send a man to the moon and safely bring him home before the end of the decade. Astronaut Michael Collins was one of those men. ...

Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study.

Patients with cardiac amyloidosis demonstrate reduced myocardial strain with associated sparing of the cardiac apex. In the APOLLO randomized clinical trial, patisiran, an RNA interference therapeutic...

APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.

The clinical utility of conventional intravenous opioids is limited by the occurrence of opioid-related adverse events (ORAEs). Oliceridine is a novel G protein-biased μ-opioid receptor agonist desig...

Rear Admiral (Astronaut) Alan Shepard: Ménière's disease and the race to the moon.

On May 5, 1961, Alan B. Shepard Jr. piloted the Freedom 7 craft into a suborbital flight to become the first American man in space. His promising astronautical career was soon scuttled by spells of di...

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Clinical Trials [195 Associated Clinical Trials listed on BioPortfolio]

INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo in Patients With Brain Hemorrhage

Objective: The primary objective of this multicenter prospective registry is to provide additional safety, technical outcomes and clinical outcomes data for minimally invasive endoscopic s...

APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

The APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon variation in the apolipoprotein...

First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent

Prospective, multi-center, randomized 1:1 single blind trial using NOVA sirolimus eluting stent versus Apollo bare metal stent conducted in approximately 15 interventional neurology center...

Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO).

Nonalcoholic steatohepatitis is a growing public health problem affecting over 5% of the population. These patients are at increased risk of cardiovascular and liver-related death and have...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Companies [1352 Associated Companies listed on BioPortfolio]

Apollo Global Management, LLC

Apollo is a leading global alternative investment manager with offices in New York, Los Angeles, Houston, Chicago, Bethesda, Toronto, London, Frankfurt, Madrid, Luxembourg, Mumbai...

Apollo Therapeutics

The Apollo Therapeutics Fund is a unique collaboration between three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline and Johnson & Johnson) and the technology transf...

Apollo Ventures

Apollo Ventures is a life science venture capital firm and company builder working across Europe and North America. Apollo is unique among investment firms due to its focus on ...

Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is dedicated to revolutionizing patient care through the development of flexible surgery, which is emerging from the convergence of laparoscopic surgery and therapeutic gastro...

Apollo Health Street

Apollo Health Street partners with the nation’s leading hospitals and healthcare organizations to achieve healthcare’s True Return – the financial strength to offer...

More Information about "Apollo Therapeutics" on BioPortfolio

We have published hundreds of Apollo Therapeutics news stories on BioPortfolio along with dozens of Apollo Therapeutics Clinical Trials and PubMed Articles about Apollo Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Apollo Therapeutics Companies in our database. You can also find out about relevant Apollo Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...


Corporate Database Quicklinks



Searches Linking to this Company Record